These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32436234)

  • 1. Effect of selective I
    Fenner MF; Carstensen H; Dalgas Nissen S; Melis Hesselkilde E; Scott Lunddahl C; Adler Hess Jensen M; Loft-Andersen AV; Sattler SM; Platonov P; El-Haou S; Jackson C; Tang R; Kirby R; Ford J; Schotten U; Milnes J; Svane Sørensen U; Jespersen T; Buhl R
    Br J Pharmacol; 2020 Aug; 177(16):3778-3794. PubMed ID: 32436234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats.
    Sobota V; Gatta G; van Hunnik A; van Tuijn I; Kuiper M; Milnes J; Jespersen T; Schotten U; Verheule S
    Front Pharmacol; 2020; 11():608410. PubMed ID: 33584287
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the acetylcholine-regulated potassium current prevents transient apnea-related atrial arrhythmogenic changes in a porcine model.
    Norup Hertel J; Linz B; Isaksen J; Jerltorp K; Leonhardt C; Gottlieb L; Saljic A; Jespersen T; Linz D
    Heart Rhythm; 2024 May; 21(5):622-629. PubMed ID: 38280622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of I
    Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].
    Brandts B; Van Bracht M; Dirkmann D; Borchard R; Wickenbrock I; Prull MW; Meine M; Trappe HJ
    Med Klin (Munich); 2004 Jul; 99(7):341-6. PubMed ID: 15322712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.
    Haugaard MM; Hesselkilde EZ; Pehrson S; Carstensen H; Flethøj M; Præstegaard KF; Sørensen US; Diness JG; Grunnet M; Buhl R; Jespersen T
    Heart Rhythm; 2015 Apr; 12(4):825-35. PubMed ID: 25542425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Properties of the Transient Outward, Inward Rectifier and Acetylcholine-Sensitive Potassium Currents in Atrial Myocytes from Dogs in Sinus Rhythm and Experimentally Induced Atrial Fibrillation Dog Models.
    Kohajda Z; Corici C; Kristóf A; Virág L; Husti Z; Baczkó I; Sághy L; Varró A; Jost N
    Pharmaceuticals (Basel); 2024 Aug; 17(9):. PubMed ID: 39338302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
    Seibertz F; Rubio T; Springer R; Popp F; Ritter M; Liutkute A; Bartelt L; Stelzer L; Haghighi F; Pietras J; Windel H; Pedrosa NDI; Rapedius M; Doering Y; Solano R; Hindmarsh R; Shi R; Tiburcy M; Bruegmann T; Kutschka I; Streckfuss-Bömeke K; Kensah G; Cyganek L; Zimmermann WH; Voigt N
    Cardiovasc Res; 2023 Dec; 119(16):2623-2637. PubMed ID: 37677054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of I
    Kambayashi R; Goto A; Izumi-Nakaseko H; Takei Y; Matsumoto A; Kawai S; Sugiyama A
    J Pharmacol Sci; 2022 Aug; 149(4):175-178. PubMed ID: 35717070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic type-1 receptors contribute to I
    Heijman J; Kirchner D; Kunze F; Chrétien EM; Michel-Reher MB; Voigt N; Knaut M; Michel MC; Ravens U; Dobrev D
    Int J Cardiol; 2018 Mar; 255():61-68. PubMed ID: 29290419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational Studies on Anti-Atrial Fibrillatory Action of Oseltamivir by its
    Kambayashi R; Izumi-Nakaseko H; Goto A; Tsurudome K; Ohshiro H; Izumi T; Hagiwara-Nagasawa M; Chiba K; Nishiyama R; Oyama S; Nunoi Y; Takei Y; Matsumoto A; Sugiyama A
    Front Pharmacol; 2021; 12():593021. PubMed ID: 33995006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.
    Ohmoto-Sekine Y; Uemura H; Tamagawa M; Nakaya H
    Br J Pharmacol; 1999 Feb; 126(3):751-61. PubMed ID: 10188988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation.
    Voigt N; Heijman J; Trausch A; Mintert-Jancke E; Pott L; Ravens U; Dobrev D
    J Mol Cell Cardiol; 2013 Aug; 61():142-52. PubMed ID: 23531443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models.
    Ji Y; Varkevisser R; Opacic D; Bossu A; Kuiper M; Beekman JDM; Yang S; Khan AP; Dobrev D; Voigt N; Wang MZ; Verheule S; Vos MA; van der Heyden MAG
    Br J Pharmacol; 2017 Aug; 174(15):2576-2590. PubMed ID: 28542844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
    Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ
    Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.
    Hesselkilde EZ; Carstensen H; Haugaard MM; Carlson J; Pehrson S; Jespersen T; Buhl R; Platonov PG
    BMC Cardiovasc Disord; 2017 Dec; 17(1):289. PubMed ID: 29221440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.
    Kambayashi R; Hagiwara-Nagasawa M; Ichikawa T; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Takahara A; Sugiyama A
    Heart Vessels; 2020 Sep; 35(9):1316-1322. PubMed ID: 32346771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Small-Conductance Calcium-Activated Potassium Current (
    Fenner MF; Gatta G; Sattler S; Kuiper M; Hesselkilde EM; Adler DMT; Smerup M; Schotten U; Sørensen U; Diness JG; Jespersen T; Verheule S; Van Hunnik A; Buhl R
    Front Physiol; 2021; 12():614483. PubMed ID: 33633584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.